Exendin-4 derivatives as dual GLP1/GIP or trigonal GLP1/GIP/glucagon agonists

A technology of peptide compounds and solvates, applied in glucagon, hormone peptides, antidote, etc., can solve the problems of chemical instability of exendin-4

Inactive Publication Date: 2015-09-09
SANOFI SA
View PDF12 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] But exendin-4 is chemically unstable due to the oxidation of methionine at position 14 (Hargrove DM et al., Regul. Pept., 141:113-9, 2007), and the methionine at position 28. Asparagine deamination and isomerization (WO 2004 / 035623)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Exendin-4 derivatives as dual GLP1/GIP or trigonal GLP1/GIP/glucagon agonists
  • Exendin-4 derivatives as dual GLP1/GIP or trigonal GLP1/GIP/glucagon agonists
  • Exendin-4 derivatives as dual GLP1/GIP or trigonal GLP1/GIP/glucagon agonists

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0597] Synthesis of SEQ ID NO:12

[0598]In Novabiochem Rink-Amide resin (4-(2',4'-dimethoxyphenyl-Fmoc-aminomethyl)-phenoxyacetamido-norleucylaminomethyl resin), 100-200 The solid-phase synthesis was carried out on a mesh with a loading of 0.34 mmol / g. The Fmoc-synthesis strategy was applied with HBTU / DIPEA-activation. Boc-Tyr(tBu)-OH at position 1 and Fmoc-Lys(ivDde)-OH at position 14 were used in the solid phase synthesis protocol. The ivDde-group was cleaved from the peptide on the resin with 4% hydrazine hydrate in DMF according to a modified literature procedure (S.R. Chhabra et al., Tetrahedron Lett. 39, (1998), 1603). Thereafter Palm-Glu(γОSu)-OtBu was coupled to the detethered amino group. Peptides were cleaved from the resin with King's mixture (D.S. King, C.G. Fields, G.B. Fields, Int. J. Peptide Protein Res. 36, 1990, 255-266). The crude product was purified by preparative HPLC on a Waters column (Sunfire, Prep C18) with an acetonitrile / water gradient, both buf...

Embodiment 2

[0600] Synthesis of SEQ ID NO:31

[0601] In Novabiochem Rink-Amide resin (4-(2',4'-dimethoxyphenyl-Fmoc-aminomethyl)-phenoxyacetamido-norleucylaminomethyl resin), 100-200 The solid phase synthesis was carried out on the loading amount of 0.34mmol / g. The Fmoc-synthesis strategy was applied with HBTU / DIPEA-activation. Boc-Tyr(tBu)-OH at position 1 and Fmoc-Lys(ivDde)-OH at position 14 were used in the solid phase synthesis protocol. The ivDde-group was cleaved from the peptide on the resin with 4% hydrazine hydrate in DMF according to a modified literature procedure (S.R. Chhabra et al., Tetrahedron Lett. 39, (1998), 1603). Thereafter Stea-Glu(γОSu)-OtBu was coupled to the detethered amino group. Peptides were cleaved from the resin with King's mixture (D.S. King, C.G. Fields, G.B. Fields, Int. J. Peptide Protein Res. 36, 1990, 255-266). The crude product was purified by preparative HPLC on a Waters column (Sunfire, Prep C18) with an acetonitrile / water gradient, both buffer...

Embodiment 3

[0603] Synthesis of SEQ ID NO:14

[0604] Solid phase synthesis was performed on Rink-resin from Agilent Technologies with a loading of 0.38 mmol / g, 75-150 μm. The Fmoc-synthesis strategy was applied with HBTU / DIPEA-activation. Boc-Tyr(tBu)-OH at position 1 and Fmoc-Lys(ivDde)-OH at position 14 were used in the solid phase synthesis protocol. The ivDde-group was cleaved from the peptide on the resin according to the literature (S.R. Chhabra et al., Tetrahedron Lett. 39, (1998), 1603). This was followed by coupling of Palm-Glu(γОSu)-OtBu to the detethered amino group using HBTU / DIPEA coupling reagent, followed by Fmoc-deprotection with 20% piperidine in DMF. Peptides were cleaved from the resin using King's mixture (D.S. King, C.G. Fields, G.B. Fields, Int. J. Peptide Protein Res. 36, 1990, 255-266). The crude product was purified by preparative HPLC on a Waters column (XBridge, BEH130, Prep C18 5 μΜ) with an acetonitrile / water gradient, both buffered with 0.1% TFA. The pur...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to exendin-4 derivatives and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as reduction of excess food intake.

Description

[0001] manual field of invention [0002] The present invention relates to exendin-4 (exendin-4) peptide analogs, which activate glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, and optionally Activation of glucagon receptors (GCG), and their medicinal use, for example in the treatment of disorders of the metabolic syndrome including diabetes and obesity and in reducing excess food intake. Background of the invention [0003] Exendin-4 is a 39 amino acid peptide produced by the Gila monster (Heloderma suspectum) (Eng J. et al., J. Biol. Chem. , 267:7402-05, 1992). Exendin-4 is an activator of the glucagon-like peptide-1 (GLP-1) receptor, however it shows only low activation of the GLP receptor and does not activate the glucagon receptor. body (see Table 1). [0004] Table 1: Potency of exendin-4 at increasing concentrations on human GLP-1, GIP and glucagon receptors (expressed in pM), and cAMP formed measured as described i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/26C07K14/605
CPCA61K38/00A61K38/26A61K38/28A61K38/2264A61K45/06C07K14/605A61P1/00A61P1/16A61P25/00A61P25/28A61P25/30A61P3/00A61P3/04A61P3/06A61P3/08A61P39/02A61P43/00A61P9/00A61P9/10A61P9/12A61P3/10Y02A50/30A61K2300/00A61K9/0019
Inventor T·哈克M·瓦格纳B·亨克尔S·斯滕格林A·埃弗斯M·洛伦茨K·洛伦茨
Owner SANOFI SA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap